A Partnership of Hope and Transformation
Every year, the lives of 74,000 cancer patients and their families are transformed by the care, specialized services, and research of UPMC CancerCenter, Partner with University of Pittsburgh Cancer Institute.
Applying good science, investing in smart technology, and putting patients first. That’s the philosophy driving the cutting-edge research and lifesaving care offered through UPMC CancerCenter, Partner with University of Pittsburgh Cancer Institute (UPCI).
“We’re committed to being a leader in the fight against cancer today and tomorrow, with the patient always at the center of all we do,” says Nancy Davidson, MD, director of UPMC CancerCenter.
“From the groundbreaking research that takes place in our laboratories to our delivery of the latest cancer therapies in locations throughout the region, we’re at the frontline of cancer prevention, detection, diagnosis, and treatment,” she says. “We also play a key role in inspiring and educating the next generation of bright young scientists and cancer specialists.”
A Network Like No Other
UPMC CancerCenter is one of the nation’s largest integrated community networks of cancer physicians and health care specialists. Its more than 30 locations throughout western Pennsylvania and Ohio bring outstanding cancer care close to home for many patients.
“One of the main strengths of the UPMC CancerCenter network is its ability to obtain virtually identical results wherever patients are treated,” says Peter Ellis, MD, director of the medical oncology network. “Our Clinical Pathways are evidence-based care standards that provide uniformity across the network.”
Three Powerful Pillars Supported by 1,700 Experts
“Through our quarter-century-long partnership, UPCI and UPMC CancerCenter have identified three pillars that enable us to achieve our common goals: clinical care, specialized care, and research,” says Stanley Marks, MD, chairman of UPMC CancerCenter.
“It’s not always easy to see the ‘behind the scenes’ story of who we are and what we do. With these three pillars, we marshal the resources of nearly 250 medical, radiation, and surgical oncology physicians; more than 1,160 nurses, technicians, and staff; and 350 research and clinical faculty,” he explains. “Few organizations in the country can match the level of scientific and medical expertise, state of-the-art technology, and physical locations found here.”
Pillar I: Clinical Care
From the moment of diagnosis, UPMC CancerCenter’s network of nearly 100 medical oncologists links patients to a full range of treatments and services that include:
- Conventional chemotherapy
- Targeted therapies
- Stem cell transplants
- Hormone therapy
- Biological therapy
- Perfusion therapy
The UPMC CancerCenter radiation oncology network includes 16 community-based radiation oncology centers and 10 dual radiation and medical oncology centers. Many of these sites offer innovative, advanced technology that allows for more precise tumor imaging and radiation treatment.
The surgical oncology network specializes in the surgical treatment of a wide variety of cancers, including many rare and difficult tumors. Its multidisciplinary team of physicians has attracted national attention for work in areas such as minimally invasive surgery, including robotic surgery; specialized procedures, such as the pancreatic Whipple; and regional perfusion therapy, which directs high concentrations of chemotherapy to the tumor site.
Pillar II: Specialized Care
For patients with challenging or late-stage cancers, UPMC’s Hillman Cancer Center is a beacon of hope and innovation. It is home to internationally regarded surgical, medical, and radiation oncology specialists who perform treatments and procedures unavailable elsewhere in the region. Hillman also has the area’s most advanced imaging technologies to detect cancer and monitor treatment.
Nationally ranked Magee-Womens Hospital of UPMC features dedicated and comprehensive women’s cancer care, including breast, ovarian, uterine, and cervical cancers.
For patients with hard-to-treat cancers, UPCI and UPMC CancerCenter offer disease-specific multidisciplinary clinics called Specialty Care Centers (SCC) designed to provide quick access to leading specialists. Many SCC reviews are done over the Internet, eliminating the need for long-distance travel.
Care for children, adolescents, and young adults with cancer is provided at the highly-ranked Children’s Hospital of Pittsburgh of UPMC.
Pillar III: Research
UPCI physicians and scientists are recognized leaders in molecular and medical oncology research. Their primary goal is to discover new ways to prevent, treat, and cure all types of cancer, particularly those with the lowest survival rates. Working hand-in-hand with UPMC CancerCenter, UPCI’s investigators strive to translate their research into actual treatment. More than 300 clinical trials now underway at UPCI give patients access to cutting-edge therapies long before they are broadly available.
The National Cancer Institute’s (NCI) 12th most-funded cancer research institution, UPCI received more than $174 million in support in 2011. UPCI is also western Pennsylvania’s only NCI-designated Comprehensive Cancer Center.
Hillman Cancer Center Celebrates 10-Year Anniversary
When the Hillman Cancer Center opened its doors in 2002, it was hailed as an architectural gem — its spectacular, glass-block walled atrium serving as a symbolic link between research and patient care.
Today, Hillman Cancer Center is the treatment and research flagship of the growing UPMC CancerCenter network. A 350,000-square-foot comprehensive cancer center, Hillman is home to UPMC CancerCenter’s pre-eminent clinical care for patients and UPCI’s internationally recognized academic and research programs. Here, patients and their families have access to specialized cancer diagnosis, prevention, care, and treatment, including multidisciplinary outpatient stem cell transplant services.
Opening in January 2013, the new Mario Lemieux Center for Blood Cancers will offer comprehensive diagnostic services, individually designed treatment plans, and long-term follow-up services to patients with leukemia, lymphoma, Hodgkin’s disease, non-Hodgkin’s lymphoma, multiple myeloma, and other blood malignancies.
To learn more about UPMC CancerCenter, Partner with University of Pittsburgh Cancer Institute, visit UPMCCancerCenter.com.